Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohnʼs Disease : A Randomized Placebo-controlled, Double-blind, Phase IIa Study
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohnʼs Disease : A Randomized Placebo-controlled, Double-blind, Phase IIa Study
:
A Randomized Placebo-controlled, Double-blind, Phase IIa Study